(NAFLD) Completed Phase 1 Trials for Pegbelfermin (DB15365)

Also known as: NAFLD

IndicationStatusPhase
DBCOND0039962 ((NAFLD))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03674476An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney FunctionTreatment